bpc 157. Orthopedic Use of BPC-157 BPC-157 for athletes and injury
Description
Unfortunately, its estimated that approximately 50% of people in the United States have a B12 deficiency, often due to dietary choices, medical conditions, or age-related factors
Frequency: one subcutaneous injection each day at a consistent time, titrating up as tolerated over a 12-week cycle
Headache: The most commonly reported adverse event was headache, characterized as mild to moderate in severity
This contains 0.9% sodium chloride plus the benzyl alcohol preservative
